Doyle Wealth Management Gilead Sciences, Inc. Transaction History

Doyle Wealth Management

13 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2020 Nov 13, 2020	SELL	$62.1 - $78.08 $177,357 - $222,996	-2,856 Closed	0 $0
Q2 2020 Aug 06, 2020	SELL	$72.34 - $84.0 $69,301 - $80,472	-958 Reduced 25.12%	2,856 $220,000
Q1 2020 Apr 29, 2020	BUY	$62.63 - $80.22 $24,300 - $31,125	388 Added 11.33%	3,814 $285,000
Q4 2019 Feb 11, 2020	SELL	$61.62 - $67.78 $8.79 Million - $9.67 Million	-142,686 Reduced 97.66%	3,426 $223,000
Q3 2019 Nov 05, 2019	SELL	$62.51 - $69.0 $195,718 - $216,039	-3,131 Reduced 2.1%	146,112 $9.26 Million
Q2 2019 Aug 15, 2019	SELL	$61.87 - $69.38 $67,562 - $75,762	-1,092 Reduced 0.73%	149,243 $10.1 Million
Q1 2019 May 13, 2019	SELL	$62.53 - $70.05 $88,104 - $98,700	-1,409 Reduced 0.93%	150,335 $9.86 Million
Q4 2018 Feb 08, 2019	SELL	$60.54 - $79.0 $484,985 - $632,869	-8,011 Reduced 5.01%	151,744 $9.49 Million
Q3 2018 Nov 08, 2018	BUY	$71.28 - $78.92 $180,267 - $199,588	2,529 Added 1.61%	159,755 $12.3 Million
Q2 2018 Aug 08, 2018	BUY	$64.88 - $75.68 $378,185 - $441,138	5,829 Added 3.85%	157,226 $11.1 Million
Q1 2018 May 11, 2018	BUY	$72.84 - $88.8 $451,535 - $550,471	6,199 Added 4.27%	151,397 $11.4 Million
Q4 2017 Feb 07, 2018	SELL	$71.15 - $83.52 $156,031 - $183,159	-2,193 Reduced 1.49%	145,198 $10.4 Million
Q3 2017 Oct 25, 2017	BUY	$72.11 - $85.47 $10.6 Million - $12.6 Million	147,391	147,391 $11.9 Million

1,927

994M

10.5M

9.75M

Ticker GILD
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 1,253,369,984
Market Cap $116B
Description
Gilead Sciences, Inc., a biopharmaceutical company, discovers, develops, and commercializes medicines in the areas of unmet medical need in the United States, Europe, and internationally. The company provides Biktarvy, Genvoya, Descovy, Odefsey, Truvada, Complera/ Eviplera, Stribild, and Atripla products for the treatment of HIV/AIDS; Veklury, a...

Get notified when there are updates to the investment portfolio of Doyle Wealth Management, based on Form 13F filings with the SEC.

Stay updated on Doyle Wealth Management with notifications on news.